Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Singularity Future Technology (SGLY) Current Deferred Revenue (2016 - 2025)

Singularity Future Technology (SGLY) has disclosed Current Deferred Revenue for 12 consecutive years, with $45691.0 as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 31.05% to $45691.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45691.0 through Dec 2025, down 31.05% year-over-year, with the annual reading at $66423.0 for FY2024, 0.16% changed from the prior year.
  • Current Deferred Revenue for Q4 2025 was $45691.0 at Singularity Future Technology, up from $44883.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $7.0 million in Q2 2022, with the low at $44883.0 in Q3 2025.
  • Average Current Deferred Revenue over 4 years is $614601.8, with a median of $66531.0 recorded in 2023.
  • The sharpest move saw Current Deferred Revenue crashed 99.04% in 2023, then rose 2.51% in 2024.
  • Over 4 years, Current Deferred Revenue stood at $204442.0 in 2022, then crashed by 66.92% to $67631.0 in 2023, then dropped by 2.02% to $66265.0 in 2024, then tumbled by 31.05% to $45691.0 in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $45691.0, $44883.0, and $65836.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.